Literature DB >> 22315646

Extraskeletal myxoid chondrosarcoma: a case report of complete remission by chemotherapy and review of the literature.

Kun Han1, Yuan-Jue Sun, Zan Shen, Jian-Jun Zhang, Feng Lin, Hui Zhao, Saleem Meerani, Yang Yao.   

Abstract

Extraskeletal myxoid chondrosarcoma is a rare soft tissue sarcoma. Surgery is the cornerstone of the management of this tumour. The response rate to chemotherapy has been very poor; with the exception of one reported case which showed promising results, overall results are disappointing because no significant radiologic or clinical responses have been noted with chemotherapy. Here we report the case of a 15-year-old girl who presented with extraskeletal myxoid chondrosarcoma in the sacrococcygeal region which was regarded as unresectable. After four cycles of chemotherapy the mass showed complete remission which has lasted >6 months.

Entities:  

Year:  2010        PMID: 22315646      PMCID: PMC3029822          DOI: 10.1136/bcr.07.2009.2128

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases.

Authors:  J M Meis-Kindblom; P Bergh; B Gunterberg; L G Kindblom
Journal:  Am J Surg Pathol       Date:  1999-06       Impact factor: 6.394

2.  A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.

Authors:  Nabeel Pervaiz; Nigel Colterjohn; Forough Farrokhyar; Richard Tozer; Alvaro Figueredo; Michelle Ghert
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

3.  Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases.

Authors:  F M Enzinger; M Shiraki
Journal:  Hum Pathol       Date:  1972-09       Impact factor: 3.466

4.  Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.

Authors:  Ioannis Panagopoulos; Fredrik Mertens; Margareth Isaksson; Henryk A Domanski; Otte Brosjö; Sverre Heim; Bodil Bjerkehagen; Raf Sciot; Paola Dal Cin; Jonathan A Fletcher; Christopher D M Fletcher; Nils Mandahl
Journal:  Genes Chromosomes Cancer       Date:  2002-12       Impact factor: 5.006

5.  Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy.

Authors:  Alex D Drilon; Sanjay Popat; Gauri Bhuchar; David R D'Adamo; Mary Louise Keohan; Cyril Fisher; Cristina R Antonescu; Samuel Singer; Murray F Brennan; Ian Judson; Robert G Maki
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

6.  Microtubule-associated protein-2 and class III beta-tubulin are expressed in extraskeletal myxoid chondrosarcoma.

Authors:  Masanori Hisaoka; Sumika Okamoto; Shune Koyama; Tsuyoshi Ishida; Tetsuo Imamura; Hiroaki Kanda; Toru Kameya; Jeanne M Meis-Kindblom; Lars-Gunnar Kindblom; Hiroshi Hashimoto
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

7.  Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow-up.

Authors:  G Saleh; H L Evans; J Y Ro; A G Ayala
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

8.  Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b.

Authors:  M Rubinger; I H Plenderleith; M Lertzman; A J Worth
Journal:  Chest       Date:  1995-07       Impact factor: 9.410

9.  Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma.

Authors:  Shailendra Verma; Jawaid Younus; Denise Stys-Norman; Adam E Haynes; Martin Blackstein
Journal:  Cancer Treat Rev       Date:  2008-03-03       Impact factor: 12.111

10.  Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy.

Authors:  S R Patel; M A Burgess; N E Papadopoulos; K A Linke; R S Benjamin
Journal:  Am J Clin Oncol       Date:  1995-04       Impact factor: 2.339

View more
  5 in total

1.  Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group.

Authors:  Anna Paioli; Silvia Stacchiotti; Domenico Campanacci; Emanuela Palmerini; Anna Maria Frezza; Alessandra Longhi; Stefano Radaelli; Davide Maria Donati; Giovanni Beltrami; Giuseppe Bianchi; Marta Barisella; Alberto Righi; Stefania Benini; Marco Fiore; Piero Picci; Alessandro Gronchi
Journal:  Ann Surg Oncol       Date:  2020-06-22       Impact factor: 5.344

2.  Myxoid chondrosarcoma of the mandible in a 22-year-old man: A case report.

Authors:  Ying Chen; Ying Zhang
Journal:  Mol Clin Oncol       Date:  2016-06-23

3.  Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.

Authors:  Silvia Stacchiotti; Gian Paolo Dagrada; Carlo Morosi; Tiziana Negri; Antonella Romanini; Silvana Pilotti; Alessandro Gronchi; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2012-10-11

4.  Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study.

Authors:  Silvia Stacchiotti; Gian Paolo Dagrada; Roberta Sanfilippo; Tiziana Negri; Isabella Vittimberga; Stefano Ferrari; Federica Grosso; Gaetano Apice; Marco Tricomi; Chiara Colombo; Alessandro Gronchi; Angelo P Dei Tos; Silvana Pilotti; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2013-12-18

5.  Symptomatic loosening of a total knee arthroplasty caused by a tibial chondrosarcoma - a case report.

Authors:  Jakob T Sieker; Maximilian Rudert; Andre F Steinert
Journal:  Springerplus       Date:  2014-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.